Libra Therapeutics Inc

Libra Therapeutics Inc. is a small biotechnology company headquartered in San Diego, California. With a team of five employees, the company focuses on developing innovative treatments for neurodegenerative diseases. Libra Therapeutics specializes in creating novel disease-modifying therapeutics aimed at restoring cellular balance disrupted in conditions like amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease, Parkinson's disease, and Huntington's disease. These diseases share a common characteristic: cellular disequilibrium caused by the overproduction and insufficient clearance of harmful proteins. The company's therapeutic platform utilizes a distinct molecular approach to discover and develop small molecule drugs. These drugs target two key mechanisms: increasing autophagy, a cellular process that efficiently removes toxic proteins, and attenuating the production of neurotoxic proteins. This dual-pronged strategy holds promise for effectively addressing the underlying causes of these debilitating diseases. For more information about Libra Therapeutics Inc. and its groundbreaking therapies, please visit their website at libratherapeutics.com.